Starting with Exelixis’ condition on in-house dispensing data, manufacturers are introducing a new approach to 340B claims focused on transparency.
|Articles|June 16, 2003
Clinical Twisters: Antipsychotic diabetes risk
Case involves an African-American schizophrenic with gestational diabetes--What antipsychotic should be ordered for her?
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Drug Topics
1
GLP-1 Therapy Must Prioritize Metabolic Quality Over Weight Loss
2
COVID-19 Vaccine Hesitancy in 2026: How Attitudes Have Shifted
3
High-Dose Vaccines Reduce Hospital Stays in Older Adults With Lung Disease
4
Social Media Best Practices for Pharmacists: Why Visibility Matters
5